Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

T-Mobile Team-Up Just Gave You Another Reason to Invest in Disney

By David Moadel, InvestorPlace Contributor
Don't be tempted to divest your DIS stock due to concerns in China, as theme parks are just part of Disney's modern business model.

Is Robinhood Stock Finally a Buy?

By Omor Ibne Ehsan
HOOD stock has seen a recent spike in price after announcing longer trading hours. Robinhood may finally have found a bottom.

3 Streaming Stocks That Are Screaming Buys Right Now

By Joel Baglole, InvestorPlace Contributor
The share prices of these streaming stocks have been beaten down, but they provide attractive buying opportunities at current levels.

7 Fintech Stocks Set to Rise from the Ashes After PayPal Plunge

By Chris Lau, InvestorPlace Contributor
Fintechs are dirt cheap while established credit card and banks are fintechs in disguise that offer the best upside after shares fell.

It’s Time to Get Clinical, Not Cynical, With Ocugen Stock

By David Moadel, InvestorPlace Contributor
The selling pressure on OCGN stock has been as heavy as a rock, but worried shareholders should celebrate Ocugen's breakthrough moments.

3 Top Cybersecurity Stocks to Buy Now

By Tezcan Gecgil, InvestorPlace Contributor
Cybersecurity stocks are getting increased attention as the war in Ukraine unnerved many companies regarding possible cyber attacks.

Opendoor’s iBuying Dominance Makes OPEN Stock a Bargain Under $10

By Tezcan Gecgil, InvestorPlace Contributor
Opendoor Technologies is the leader in iBuying, and OPEN stock will likely reflect that leadership in the coming quarters.

$18 Is the Next Target for Gevo Stock as Big Purchase Orders Come In

By David Moadel, InvestorPlace Contributor
Big-money contracts for sustainable aviation fuel should finally get GEVO stock to well-deserved higher price points in 2022.

Novavax Stock Is a Bet on Interest From Unvaccinated People

By Alex Sirois, InvestorPlace Contributor
NVAX stock represents a vaccine that lacks approval. There is real appeal behind the narrative, as it may appeal to unvaccinated people.

Teladoc Health Is a Cathie Wood Stock That You Need Now

By David Moadel, InvestorPlace Contributor
TDOC stock is under selling pressure, but fast-growing revenue and a team-up with an e-commerce giant should put Teladoc back on track.

7 Blue-Chip Stocks With Dividends to Add to Your Buy List

By Muslim Farooque, InvestorPlace Contributor
Fed rate hikes have investors looking to reduce market risk and find consistent shareholder value. These blue-chip stocks offer robust dividend yields with a consistent record of payouts.

Alphabet Stock: The Conservative Choice for Cloud Investors

By Dana Blankenhorn, InvestorPlace Contributor
Alphabet is an unstoppable profit machine, and GOOG stock is a conservative play for conservative investors who want steady capital gains.

It’s a Good Idea to Buy Amazon Stock Before the Share Split

By David Moadel, InvestorPlace Contributor
If you feel that AMZN stock has gotten too pricey, get ready for the floodgates to open as a major event will bring investors into the fold. Multi-billion-dollar share buyback plans underscore the upside potential of AMZN stock.

The 7 Most Undervalued Stocks to Buy in April

By Alex Sirois, InvestorPlace Contributor
These are the seven most undervalued stocks to consider purchasing as we head into April in consideration of a complex, troubled economy.

Battery Technology Could Give Mullen Automotive the Charge It Needs

By David Moadel, InvestorPlace Contributor
Mullen is making a wise business choice by offering strong EVs at a reasonable price. MULN stock is likely ready to stage a serious comeback.

Investors Seek Second Act with Moderna Stock

By Dana Blankenhorn, InvestorPlace Contributor
Moderna hopes its combination vaccine for COVID and the flu can keep profits high but investors are skeptical. MRNA stock struck gold with its Covid-19 vaccine but investors want to know if there are any other blockbusters in its pipeline.

Sunrun Stock Is Ready to Run Back to $60 Again

By David Moadel, InvestorPlace Contributor
RUN stock keeps hitting its head on a hard resistance level, but a breakthrough is imminent as the renewable energy movement is unstoppable.

Expect RBLX Stock to Hit $60 and Higher as Roblox Gets Big-Bank Nod

By David Moadel, InvestorPlace Contributor
Even without the Covid-19 catalysts from 2020, RBLX stock can still power higher in light of Roblox's impressive active user base growth.

4 Reasons Why NIO Is Worth Buying and Holding

By Shanthi Rexaline
Nio reported quarterly results that could not allay all fears that investors were harboring. All the same, the management commentary on the earnings call provided enough and more reasons for staying invested in the stock
Load More Articles